ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Final overall survival (OS) results of befotertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)

Lu, S.; Zhang, Y.; Zhang, G.; Zhou, J.; Cang, S.; Cheng, Y.; Wu, G.; Cao, P.; Lv, D.; Jian, H.; Chen, C.; Jin, X.; Tian, P.; Wang, K.; Jiang, G.; Chen, G.; Chen, Q.; Zhao, H.; Ding, C.; Ding, L.安徽医科大学; 华中科技大学; 上海交通大学; 哈尔滨医科大学; 河北医科大学; 四川大学; 浙江大学; 郑州大学; 中国科学院研究生院; 1; 东莞市人民医院
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)2023-11DOI: 10.1016/j.annonc.2023.10.565
5阅读
引用收藏
分享
相关
加载中…
  • Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer: A multicentre, open-label, randomized phase III study
    Lu, S.; Zhou, J.; Jian, H.; Wu, L.; Cheng, Y.; Fan, Y.; Fang, J.; Chen, G.; Zhang, Z.; Lv, D.; Jiang, L.; Wu, R.; Jin, X.; Zhang, X.; Zhang, J.; Sun, G.; Huang, D.; Cui, J.; Guo, R.; Ding, L.ESMO Asia Congress, Singapore, SINGAPORE, 2022-12-02 To 2022-12-04.
  • A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
    Lu, S.; Zhang, Y.; Zhang, G.; Zhou, J.; Cang, S.; Cheng, Y.; Wu, G.; Cao, P.; Lv, D.; Jian, H.; Chen, C.; Jin, X.; Tian, P.; Wang, K.; Jiang, G.; Chen, G.; Chen, Q.; Zhao, H.; Ding, C.; Guo, R.; Sun, G.; Wang, B.; Jiang, L.; Liu, Z.; Fang, J.; Yang, J.; Zhuang, W.; Liu, Y.; Zhang, J.; Pan, Y.; Chen, J.; Yu, Q.; Zhao, M.; Cui, J.; Li, D.; Yi, T.; Yu, Z.; Yang, Y.; Zhang, Y.; Zhi, X.; Huang, Y.; Wu, R.; Chen, L.; Zang, A.; Cao, L.; Li, Q.; Li, X.; Song, Y.; Wang, D.; Zhang, S.
  • Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study
    Lu, Shun; Zhang, Yiping; Zhang, Guojun; Zhou, Jianying; Cang, Shundong; Cheng, Ying; Wu, Gang; Cao, Peiguo; Lv, Dongqing; Jian, Hong; Chen, Chengshui; Jin, Xiangming; Tian, Panwen; Wang, Kai; Jiang, Guanming; Chen, Gongyan; Chen, Qun; Zhao, Hui; Ding, Cuimin; Guo, Renhua; Sun, Guoping; Wang, Bin; Jiang, Liyan; Liu, Zhe; Fang, Jian; Yang, Junquan; Zhuang, Wu; Liu, Yunpeng; Zhang, Jian; Pan, Yueyin; Chen, Jun; Yu, Qitao; Zhao, Min; Cui, Jiuwei; Li, Dianming; Yi, Tienan; Yu, Zhuang; Yang, YanJournal of Thoracic Oncology, 2022, 17(10): 1192-1204.被引 7
查看全部 →

会议信息

会议名称
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
会议日期
2023-12-01 至 2023-12-03
论文集名
ANNALS OF ONCOLOGY
发表日期
2023-11
起止页码
S1654-S1654
DOI
10.1016/j.annonc.2023.10.565
资助标注
Betta Pharmaceuticals Co., Ltd.
收录
ISTP · SCIE

作者

  • L

    Lu, S. (第一作者)

    shanghai jiao tong univ

  • Z

    Zhang, Y.

    univ chinese acad sci · zhejiang canc hosp

查看全部 20 位作者收起作者
  • Z

    Zhang, G.

    1 · zhengzhou univ

  • Z

    Zhou, J.

    1 · zhejiang univ

  • C

    Cang, S.

    henan prov peoples hosp

  • C

    Cheng, Y.

  • W

    Wu, G.

    huazhong univ sci & technol

  • C

    Cao, P.

  • L

    Lv, D.

  • J

    Jian, H.

    shanghai jiao tong univ

  • C

    Chen, C.

    1 · wenzhou med univ

  • J

    Jin, X.

    ningxia med univ

  • T

    Tian, P.

    sichuan univ

  • W

    Wang, K.

    1 · 2 · zhejiang univ

  • J

    Jiang, G.

    dongguan peoples hosp

  • C

    Chen, G.

    harbin med univ

  • C

    Chen, Q.

  • Z

    Zhao, H.

    2 · anhui med univ

  • D

    Ding, C.

    hebei med univ

  • D

    Ding, L.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417